Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015-2021.

Liu, Wen-Yi; Hsu, Chia-Hsien; Liu, Ting-Jun; Chen, Pei-En; Zheng, Boyuan; Chien, Ching-Wen; Tung, Tao-Hsin

Liu, Wen-Yi; Hsu, Chia-Hsien; Liu, Ting-Jun; Chen, Pei-En; Zheng, Boyuan; Chien, Ching-Wen; Tung, Tao-Hsin.

Afiliação

Liu WY; Department of Health Policy Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Hsu CH; Institute for Hospital Management, Tsing Hua University, Shenzhen, China.
Liu TJ; Shanghai Bluecross Medical Science Institute, Shanghai, China.
Chen PE; Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, China.
Zheng B; Tai Kang Institute of Healthcare Management, Beijing, China.
Chien CW; Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
Tung TH; Institute for Hospital Management, Tsing Hua University, Shenzhen, China.

Front Med (Lausanne) ; 8: 618046, 2021.

Article em En | MEDLINE | ID: mdl-34368173

Palavras-chave

China; healthcare; medical expenditure; systematic review; zero-markup policy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google